Treatment of Acne Scarring With a Novel Procedure Combination
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00510055 |
Recruitment Status :
Completed
First Posted : August 1, 2007
Last Update Posted : December 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acne Scarring | Procedure: subdermal manipulation ONLY Procedure: subdermal manipulation AND injection of a filler | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Subcision and Calcium Hydroxylapatite (Radiesse) Injection on Rolling Acne Scarring Appearance |
Study Start Date : | June 2007 |
Actual Primary Completion Date : | July 2009 |
Actual Study Completion Date : | July 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: A
scars receive subdermal manipulation ONLY
|
Procedure: subdermal manipulation ONLY
scars receive subdermal manipulation ONLY
Other Name: subcision |
Experimental: B
scars receive subdermal manipulation AND injection of a filler
|
Procedure: subdermal manipulation AND injection of a filler
scars receive subdermal manipulation AND injection of a filler
Other Name: Radiesse |
- Scar Improvement [ Time Frame: 3.5 months ]
- Adverse Events [ Time Frame: 3.5 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18 and over
- Have two acne scar areas
- The subjects are in good health
- The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
Exclusion Criteria:
- Under 18 years of age
- Pregnancy or Lactation
- Subjects who are unable to understand the protocol or to give informed consent
- Subjects with mental illness

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00510055
United States, Illinois | |
Northwestern University Feinberg School of Medicine, Department of Dermatology | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Murad Alam, MD | Northwestern University |
Responsible Party: | Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University |
ClinicalTrials.gov Identifier: | NCT00510055 |
Other Study ID Numbers: |
STU752 |
First Posted: | August 1, 2007 Key Record Dates |
Last Update Posted: | December 2, 2021 |
Last Verified: | November 2021 |
Cicatrix Fibrosis Pathologic Processes |